Clinical and translational results of CALGB 40601: A neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer Meeting Abstract
| Authors: | Carey, L. A.; Berry, D. A.; Ollila, D.; Harris, L.; Krop, I. E.; Weckstein, D.; Henry, N. L.; Anders, C. K.; Cirrincione, C.; Winer, E. P.; Perou, C. M.; Hudis, C. |
| Abstract Title: | Clinical and translational results of CALGB 40601: A neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419600007 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.500 |
| Notes: | Meeting Abstract: 500 -- Source: Wos |
